China Biologic Products Inc (CBPO):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C9831)
◆英語タイトル:China Biologic Products Inc (CBPO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9831
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:65
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
China Biologic Products Inc (China Biologic) is a biopharmaceutical company that offers plasma collection, research and development, production, commercialization of biopharmaceutical products and development of treatment products. The company manufactures, develops, and markets biologic products for the prevention and treatment of various diseases. Its plasma products include human albumin, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin for intravenous injection, human hepatitis B immunoglobulin, thymopolypeptides injection, human immunoglobulin, and human coagulation factor VIII. China Biologic’s other product includes placenta polypeptide. The company provides services such as plasma collection, research and development, production, and commercialization of biopharmaceutical products. It offers products to hospitals and other healthcare facilities in China. China Biologic is headquartered in Beijing, China.

China Biologic Products Inc (CBPO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Biologic Products Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
China Biologic Products Inc, Medical Devices Deals, 2012 to YTD 2018 9
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
China Biologic Products to Raise USD590 Million in Private Placement of Shares 11
Consortium of Investors to Acquire Remaining Shares in China Biologic Products for USD3.9 Billion 13
CCRE Holdings to Acquire Remaining 94.9% Stake in China Biologic Products 15
Equity Offering 16
China Biologic Products Raises Funds through Public Offering of Shares 16
China Biologic Prices Public Offering of Shares for USD73.5 Million 18
China Biologic Prices Public Offering of Shares for USD30 Million 19
Acquisition 21
China Biologic Products Acquires Remaining 15.3% Stake in Guizhou Taibang Biological Products for USD62.5 Million 21
China Biologic Products Inc – Key Competitors 22
China Biologic Products Inc – Key Employees 23
China Biologic Products Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Nov 01, 2018: China Biologic reports financial results for the third quarter of 2018 25
Aug 03, 2018: China Biologic reports financial results for the second quarter of 2018 31
May 04, 2018: China Biologic Reports Financial Results For First Quarter Of 2018 37
May 04, 2018: China Biologic Announces First Quarter 2018 Financial Results 40
Feb 28, 2018: China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017 43
Nov 01, 2017: China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017 47
Aug 02, 2017: China Biologic Reports Financial Results for the Second Quarter of 2017 51
May 03, 2017: China Biologic Reports Financial Results for the First Quarter of 2017 55
Feb 23, 2017: China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 58
Corporate Communications 62
Aug 13, 2018: China Biologic names Bing Li as new CEO 62
Legal and Regulatory 63
Aug 28, 2018: China Biologic responds to lawsuit filed in Cayman Islands by former Chairman 63
Other Significant Developments 64
Jan 08, 2018: China Biologic Announces Corporate Update 64
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65

List of Tables
China Biologic Products Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Biologic Products Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Biologic Products Inc, Deals By Therapy Area, 2012 to YTD 2018 8
China Biologic Products Inc, Medical Devices Deals, 2012 to YTD 2018 9
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
China Biologic Products to Raise USD590 Million in Private Placement of Shares 11
Consortium of Investors to Acquire Remaining Shares in China Biologic Products for USD3.9 Billion 13
CCRE Holdings to Acquire Remaining 94.9% Stake in China Biologic Products 15
China Biologic Products Raises Funds through Public Offering of Shares 16
China Biologic Prices Public Offering of Shares for USD73.5 Million 18
China Biologic Prices Public Offering of Shares for USD30 Million 19
China Biologic Products Acquires Remaining 15.3% Stake in Guizhou Taibang Biological Products for USD62.5 Million 21
China Biologic Products Inc, Key Competitors 22
China Biologic Products Inc, Key Employees 23
China Biologic Products Inc, Subsidiaries 24

List of Figures
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
China Biologic Products Inc, Medical Devices Deals, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ China Biologic Products Inc (CBPO):製薬・医療:M&Aディール及び事業提携情報(China Biologic Products Inc (CBPO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆